Our result may highlight again adrenoceptor-UCP1 system in pharmacological approach to obesity treatment, which has repeatedly been confirmed in experimental animals [14], [15], [34], [35], but not yet approved in humans. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.